Matrix Healthcare Solutions,

When Partnership Matters

<p>Led by industry experts with over 100 years experience across key supply models and geographies in both licensed and unlicensed medicine</p>
 image

Led by industry experts with over 100 years experience across key supply models and geographies in both licensed and unlicensed medicine

<p>Our executive team have built and run businesses across 5 continents</p>
 image

Our executive team have built and run businesses across 5 continents

<p>True partnership model designed with your long term strategy in mind</p>
 image

True partnership model designed with your long term strategy in mind

Prior to commencing a Clinical Trial or Product Acquisition, we 5 offer support services to assist our customers in making the informed and considered choices.

  • Commercial Evaluation
  • Market Research/analysis
  • Risk Assessment
  • Competitor Analysis
  • Project management
  • Product Identification


    What We Do

    Prior to commencing a Clinical Trial or Product Acquisition, we 5 offer support services to assist our customers in making the informed and considered choices.

  • Commercial Evaluation
  • Market Research/analysis
  • Risk Assessment
  • Competitor Analysis
  • Project management
  • Product Identification

    What We Do

    Prior to commencing a Clinical Trial or Product Acquisition, we 5 offer support services to assist our customers in making the informed and considered choices.

  • Commercial Evaluation
  • Market Research/analysis
  • Risk Assessment
  • Competitor Analysis
  • Project management
  • Product Identification

    What We Do


    During the Early Stages of your Clinical Trial, Matrix offers:

  • Protocol Design Consultation
  • Comparator Budgeting
  • Co-Medicine Identification
  • Bespoke Procurement of Analytical Samples / RLD’s.
  • Inception, Planning & Early Phase Activities


    What We Do

    During the Early Stages of your Clinical Trial, Matrix offers:

  • Protocol Design Consultation
  • Comparator Budgeting
  • Co-Medicine Identification
  • Bespoke Procurement of Analytical Samples / RLD’s.
  • Inception, Planning & Early Phase

    What We Do

    During the Early Stages of your Clinical Trial, Matrix offers:

  • Protocol Design Consultation
  • Comparator Budgeting
  • Co-Medicine Identification
  • Bespoke Procurement of Analytical Samples / RLD’s.
  • Inception, Planning & Early Phase Activities

    What We Do


    As your Trial progresses and evolves, so do services offered through Partnership with Matrix

  • Procurement: - Comparator - Co-Medicine - Ancillaries - Consumables - Placebos
  • Bottle to Body Solutions
  • Inventory Management
  • Clinical Sites - Seeding for SiV’s - Site Distribution
  • Blinding
  • Early-Phase Clinical Trial Solutions


    What We Do

    As your Trial progresses and evolves, so do services offered through Partnership with Matrix

  • Procurement: - Comparator - Co-Medicine - Ancillaries - Consumables - Placebos
  • Bottle to Body Solutions
  • Inventory Management
  • Clinical Sites - Seeding for SiV’s - Site Distribution
  • Blinding
  • Early-Phase Clinical Trial Solutions

    What We Do

    As your Trial progresses and evolves, so do services offered through Partnership with Matrix

  • Procurement: - Comparator - Co-Medicine - Ancillaries - Consumables - Placebos
  • Bottle to Body Solutions
  • Inventory Management
  • Clinical Sites - Seeding for SiV’s - Site Distribution
  • Blinding
  • Early-Phase Clinical Trial Solutions

    What We Do


    During the Later stages of your Clinical Trial, Matrix offers:

  • Adjustment of Supply Strategy to reduce material wastage / overage
  • Bulk procurement
  • Temperature stability services
  • Late-Phase Clinical Trial Solutions


    What We Do

    During the Later stages of your Clinical Trial, Matrix offers:

  • Adjustment of Supply Strategy to reduce material wastage / overage
  • Bulk procurement
  • Temperature stability services
  • Late-Phase Clinical Trial Solutions

    What We Do

    During the Later stages of your Clinical Trial, Matrix offers:

  • Adjustment of Supply Strategy to reduce material wastage / overage
  • Bulk procurement
  • Temperature stability services
  • Late-Phase Clinical Trial Solutions

    What We Do


  • Named Patient supply solutions
  • Reconciliation of Site Supplies - Product disposal and destruction
  • Continued supply of product to treatment naive patients through named patient progam.
  • Aftercare & Ethical Access Strategies


    What We Do

  • Named Patient supply solutions
  • Reconciliation of Site Supplies - Product disposal and destruction
  • Continued supply of product to treatment naive patients through named patient progam.
  • Aftercare & Ethical Access Strategies

    What We Do

  • Named Patient supply solutions
  • Reconciliation of Site Supplies - Product disposal and destruction
  • Continued supply of product to treatment naive patients through named patient progam.
  • Aftercare & Ethical Access Strategies

    What We Do


    Often, Generic competition erodes the market share of once high-performing products. In some cases, maintaining a license (MA) in certain markets is no longer fiscally possible. At Matrix, we:

  • Maintain Market Access on an un-licensed basis.
  • Reinvigorate down trending market performance.
  • Manage your individual or portfolio of Specialty & Biologic assets to ensure maximum market capitalisation.
  • Asset Revitalisation & Portfolio Management


    What We Do

    Often, Generic competition erodes the market share of once high-performing products. In some cases, maintaining a license (MA) in certain markets is no longer fiscally possible. At Matrix, we:

  • Maintain Market Access on an un-licensed basis.
  • Reinvigorate down trending market performance.
  • Manage your individual or portfolio of Specialty & Biologic assets to ensure maximum market capitalisation.
  • Asset Revitalisation & Portfolio Management

    What We Do

    Often, Generic competition erodes the market share of once high-performing products. In some cases, maintaining a license (MA) in certain markets is no longer fiscally possible. At Matrix, we:

  • Maintain Market Access on an un-licensed basis.
  • Reinvigorate down trending market performance.
  • Manage your individual or portfolio of Specialty & Biologic assets to ensure maximum market capitalisation.
  • Asset Revitalisation & Portfolio Management

    What We Do


  • Post Trial awareness and pre launch commercialisation
  • Bespoke Market Launch
  • Maximisation of regional product value.
  • Product Launch & Commercialisation


    What We Do

  • Post Trial awareness and pre launch commercialisation
  • Bespoke Market Launch
  • Maximisation of regional product value.
  • Product Launch & Commercialisation

    What We Do

  • Post Trial awareness and pre launch commercialisation
  • Bespoke Market Launch
  • Maximisation of regional product value.
  • Product Launch & Commercialisation

    What We Do


    In cases where assets are no longer part of your organisations core portfolio, or are no longer possible to maintain. We can:

  • Secure a mutually beneficial sale of asset on an agreed timeline.
  • Establish a transfer agreement whereby Matrix takes ownership and responsibility of your product in selected markets.
  • Product Divestment


    What We Do

    In cases where assets are no longer part of your organisations core portfolio, or are no longer possible to maintain. We can:

  • Secure a mutually beneficial sale of asset on an agreed timeline.
  • Establish a transfer agreement whereby Matrix takes ownership and responsibility of your product in selected markets.
  • Product Divestment

    What We Do

    In cases where assets are no longer part of your organisations core portfolio, or are no longer possible to maintain. We can:

  • Secure a mutually beneficial sale of asset on an agreed timeline.
  • Establish a transfer agreement whereby Matrix takes ownership and responsibility of your product in selected markets.
  • Product Divestment

    What We Do


    Why Partner With MHS?


      <p>Market Leading Supply Network</p>
 image

      Market Leading Supply Network

      <p>Ethical Approach to Sourcing</p>
 image

      Ethical Approach to Sourcing

      <p>Global Presence</p>
 image

      Global Presence

      <p>Value for Money</p>
 image

      Value for Money

      <p>Secure Supply Chain</p>
 image

      Secure Supply Chain

      <p>Patient Centric</p>
 image

      Patient Centric

    News